Enzyme ALV003 Treatment May Protect Celiac Patients From Gluten-Induced Injury

The gluten-specific enzyme ALV003 reduces a patient's exposure to gluten and its potential harm, according to a new phase 2 study appearing in Gastroenterology. It's the first time a non-dietary intervention has been shown to potentially benefit celiac disease patients.   read more

Read the whole article on

More from